Recombinant multi-species IL-5/IL5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine IL-5/IL5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a cytokine that acts as a growth and differentiation factor for both B cells and eosinophils. The encoded cytokine plays a major role in the regulation of eosinophil formation, maturation, recruitment and survival. The increased production of this cytokine may be related to pathogenesis of eosinophil-dependent inflammatory diseases. This cytokine functions by binding to its receptor, which is a heterodimer, whose beta subunit is shared with the receptors for interleukine 3 (IL3) and colony stimulating factor 2 (CSF2/GM-CSF). This gene is located on chromosome 5 within a cytokine gene cluster which includes interleukin 4 (IL4), interleukin 13 (IL13), and CSF2 . This gene, IL4, and IL13 may be regulated coordinately by long-range regulatory elements spread over 120 kilobases on chromosome 5q31. [provided by RefSeq, Jul 2013]
The Alternative Names of target: B-cell differentiation factor I,EDF,Eosinophil differentiation factor,IL-5,IL5,Il-5,Il5,Interleukin-5,T-cell replacing factor (TRF),TRF

Target products collectionGo to IL-5/IL5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T78585-Ag-1/ GM-Tg-hg-T78585-Ag-2 Human IL-5/IL5 protein Human
GM-Tg-rg-T78585-Ag-1/ GM-Tg-rg-T78585-Ag-2 Rat IL-5/IL5 protein Rat
GM-Tg-mg-T78585-Ag-1/ GM-Tg-mg-T78585-Ag-2 Mouse IL-5/IL5 protein Mouse
GM-Tg-cynog-T78585-Ag-1/ GM-Tg-cynog-T78585-Ag-2 Cynomolgus/Rhesus macaque IL-5/IL5 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T78585-Ag-1/ GM-Tg-felg-T78585-Ag-2 Feline IL-5/IL5 protein Feline
GM-Tg-cang-T78585-Ag-1/ GM-Tg-cang-T78585-Ag-2 Canine IL-5/IL5 protein Canine
GM-Tg-bovg-T78585-Ag-1/ GM-Tg-bovg-T78585-Ag-2 Bovine IL-5/IL5 protein Bovine
GM-Tg-equg-T78585-Ag-1/ GM-Tg-equg-T78585-Ag-2 Equine IL-5/IL5 protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T78585-Ag-1/ GM-Tg-hg-T78585-Ag-2; GM-Tg-rg-T78585-Ag-1/ GM-Tg-rg-T78585-Ag-2;
GM-Tg-mg-T78585-Ag-1/ GM-Tg-mg-T78585-Ag-2; GM-Tg-cynog-T78585-Ag-1/ GM-Tg-cynog-T78585-Ag-2;
GM-Tg-felg-T78585-Ag-1/ GM-Tg-felg-T78585-Ag-2; GM-Tg-cang-T78585-Ag-1/ GM-Tg-cang-T78585-Ag-2;
GM-Tg-bovg-T78585-Ag-1/ GM-Tg-bovg-T78585-Ag-2; GM-Tg-equg-T78585-Ag-1/ GM-Tg-equg-T78585-Ag-2
Products Name IL-5/IL5 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name IL-5/IL5
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine IL-5/IL5 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.